Study Summary
This trial will compare a shorter course of radiation therapy to the standard of care for brain cancer patients. It hopes to find a more effective treatment with fewer side effects.
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
1 Primary · 3 Secondary · Reporting Duration: From baseline up to 3 years
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
2 Treatment Groups
Arm B (standard course RT)
1 of 2
Arm A (short course RT)
1 of 2
Active Control
Experimental Treatment
170 Total Participants · 2 Treatment Groups
Primary Treatment: Arm A (short course RT) · No Placebo Group · Phase 2
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 0 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Is this trial currently recruiting participants?
"Per information held on clinicaltrials.gov, the aforementioned medical trial is no longer searching for patients. Initially posted in March 27th 2023, with its last update dated March 19th 23rd; however 458 other studies are still recruiting participants as of now." - Anonymous Online Contributor
Does the Food and Drug Administration recognize Arm A (short course RT) as being an acceptable therapeutic approach?
"Our team at Power has ascribed a score of 2 to Arm A (short course RT) on the basis that this is Phase 2 trial, which implies there are some data suggesting safety but no evidence supporting efficacy." - Anonymous Online Contributor